Home › Drug Codes › Q Codes › Q2017 · TENIPOSIDE
Updated July 1st, 2026

TENIPOSIDE Q Code: Q2017

Injection, teniposide, 50 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, teniposide, 50 mg
HCPCS Added Date July 1, 2000
Manufacturer WG Critical Care
Generic Status HCPCS Discontinued

About TENIPOSIDE

Teniposide is a medication aligned to the HCPCS Q Code: Q2017 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug manufactured by WG Critical Care.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to Q2017. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

TENIPOSIDE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Teniposide (Q2017) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q2017. Wastage billing guide →

TENIPOSIDE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Refractory childhood acute lymphoblastic leukemia

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Teniposide billing and coding guide?
We have not yet identified a manufacturer source of Teniposide billing and coding information.
Are there any available Teniposide patient assistance programs?
Our team did not identify a source for Teniposide patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Teniposide prescribing information?
TENIPOSIDE prescribing information can be found at the link below: Visit Here →
Where can I find Teniposide side effect information?
Information regarding TENIPOSIDE's side effects can be found at MedlinePlus Visit Here →
Does billing TENIPOSIDE require JZ/JW wastage modifiers?
CMS does not include TENIPOSIDE (Q2017) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q2017. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.